Triciribine Engages ZFP36L1 and HuR to Stabilize LDLR mRNA

An increased understanding of low-density lipoprotein receptor (LDLR) and its regulation may facilitate drug development for the treatment of hypercholesterolemia. Triciribine (TCN), which is a highly selective AKT inhibitor, increases the stability of LDLR mRNA downstream of extracellular signal-re...

Descripción completa

Detalles Bibliográficos
Autor principal: Sundvold, Hilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583736/
https://www.ncbi.nlm.nih.gov/pubmed/33019656
http://dx.doi.org/10.3390/molecules25194505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583736/
https://www.ncbi.nlm.nih.gov/pubmed/33019656
http://dx.doi.org/10.3390/molecules25194505

Ejemplares similares